Tango Therapeutics, Inc.: cashflow_financing

Value{"amount": 82406000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityTango Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-24-032516 · Open the official SEC filing →
Retrieved: 2026-08-19T18:17:35.703091+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001819133/cashflow-financing/2023-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/da906b0d-cf38-41c4-8a29-79ea5ce378d2

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies